Research Areas
In this section, by far, most Axon Ligands™ are categorized as research tools that find their application in cell signaling and oncology. Targeting a multitude of specific enzymes and receptors, they either stimulate or block particular cellular signaling pathways that are implicated in various kinds of cancer. Naturally, all products in this section can also be found by their specific biological targets as listed in the sections of enzymes, receptors, transcription factors, proteins and/or signaling pathways. Besides the comprehensive set of compounds that targe cell signaling and oncology, selections of Axon Ligands™ have also been made for other research area's such as cardiovascular diseases, angiogenisis, epigenetics, stem cell research, among many others.
| Axon ID | Name | Description | From price | |
|---|---|---|---|---|
| 3755 | (+)-Abscisic acid | LANCL2 ligand | €90.00 | |
| 1066 | N-Cyclopropyl-N-methyl-2-aminotetraline hydrobromide | MAO inhibitor | €95.00 | |
| 1064 | Prop-2-ynyl-2-aminotetraline hydrochloride | Dopamine agonist | Inquire | |
| 2534 | (+)-Azasetron hydrochloride | 5-HT3 antagonist | €135.00 | |
| 3144 | (+)-Blebbistatin | Negative control of (±)-Blebbistatin as an inhibitor of class II myosins | €90.00 | |
| 1077 | (+)-Epibatidine dihydrochloride | Nicotinic acetylcholine receptor agonist | €155.00 | |
| 2467 | (+)-ITD-1 | Selective inhibitor of TGFβ/Smad signaling that promotes cardiogenesis | €165.00 | |
| 1989 | (+)-JQ1 |
Potent and selective BET bromodomain inhibitor |
€60.00 | |
| 3822 | (+)-JQ1 carboxylic acid | (+)-JQ1 derivative; PROTAC precursor | €110.00 | |
| 1730 | (+)-Kifunensine | α-mannosidase inhibitor | €120.00 | |
| 1107 | (+)-MDL 105725 | 5-HT2A antagonist | €130.00 | |
| 1594 | (+)-Pagoclone | GABAA-α2 and GABAA-α3 agonist | €135.00 | |
| 1073 | (+)-PD128907 hydrochloride | D3 agonist | €120.00 | |
| 1071 | (+)-PHNO hydrochloride | D2 agonist | €110.00 | |
| 2239 | (+)-ZK 216348 | Selective nonsteroidal glucocorticoid receptor (GR) agonist | €125.00 | |
| 2535 | (-)-Azasetron hydrochloride | 5-HT3 antagonist | €135.00 | |
| 3074 | (-)-Blebbistatin | Selective inhibitor of class II myosins; Active enantiomer of (±)-Blebbistatin | €90.00 | |
| 1078 | (-)-Epibatidine dihydrochloride | Nicotinic acetylcholine receptor agonist | €155.00 | |
| 3873 | (-)-JQ-1 | Inactive enantiomer of (+)-JQ1 | €120.00 | |
| 1108 | (-)-MDL 105725 | 5-HT2A antagonist | Inquire | |
| 1092 | (-)-NPPCC | 5-HT1A agonist | Inquire | |
| 1074 | (-)-PD128907 hydrochloride | D3 agonist | Inquire | |
| 1359 | (-)-WAY 100135 dihydrochloride | 5-HT1A antagonist | €95.00 | |
| 3759 | (aR)-RP-6306 | (aR)-enantiomer of RP-6306 (Axon 3668); PKMYT1 inhibitor | €180.00 | |
| 1049 | (R)-(+)-5-methoxy-2-aminotetraline hydrochloride | Dopamine agonist | Inquire | |
| 1013 | (R)-(+)-7-Hydroxy-DPAT hydrobromide | D3 agonist | Inquire | |
| 1030 | (R)-(+)-7-Methoxy-N-propyl-2-aminotetraline hydrochloride | Building Block; unknown pharmacology | €225.00 | |
| 1016 | (R)-(+)-8-Hydroxy-DPAT hydrobromide | 5-HT1A agonist | €105.00 | |
| 1058 | (R)-(+)-8-Methoxy-2-aminotetraline hydrochloride | Building Block; 5-HT1A agonist | Inquire | |
| 1758 | (R)-(+)-BAY K 8644 | Calcium (Ca2+) channel modulator | €115.00 | |